CORCEPT THERAPEUTICS INC - 8-K Filing
Sean Maduck resigns as President of Corcept Endocrinology, effective October 1, 2026; Justin Gunn appointed successor. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $CORT
Read the full article at SEC EDGAR
Part of the story TriplePoint Venture Growth BDC Corp. - 8-K Filing (197 articles)